Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Three patients suffered severe health issues due to not getting enough vitamins and minerals after weight-loss surgery.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

PCOS understanding and treatment are advancing, requiring continuous updates for better patient management.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Latanoprost can make eyelashes longer, thicker, and darker.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Follicular unit grafting is a procedure used to treat hair loss, where small hair grafts are placed into the scalp, with future treatments likely to involve smaller incisions and cell-based therapies.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.